Merck News
5 FOLLOWERS
Review the archive of Merck's news releases. Explore clinical trial results, the latest research breakthroughs, collaborations, and more medical news. Merck is a research-intensive biopharmaceutical company using the power of leading-edge science to save and improve lives around the world.
Merck News
1M ago
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070 ..read more
Merck News
1M ago
Merck Provides Update on Phase 3 KeyVibe-008 Trial Evaluating an Investigational Fixed-Dose Combination of Vibostolimab and Pembrolizumab in Patients With Extensive-Stage Small Cell Lung Cancer ..read more
Merck News
1M ago
Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants ..read more
Merck News
1M ago
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma ..read more
Merck News
2M ago
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer ..read more
Merck News
2M ago
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza ..read more
Merck News
2M ago
Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH ..read more
Merck News
2M ago
CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults ..read more
Merck News
2M ago
Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30 ..read more